Pancreatic Neuroendocrine Tumors

Overview

Journal Indian J Gastroenterol

Specialty Gastroenterology

Date 2012 Oct 12

PMID 23054950

Citations 3

Authors

Shailesh V Shrikhande

Bhawna Sirohi

Mahesh Goel

Savio G Barreto

Affiliations

Soon will be listed here.

Abstract

Pancreatic neuroendocrine tumors (pancreatic NETs) are rare, low- to intermediate-grade neoplasms thought to arise from the pancreatic islets. Recent advances in pathology and our understanding of the biological behavior of this group of tumors has resulted in changes in their nomenclature and how we treat them. This review puts into perspective our current understanding of pancreatic NETs in terms of their incidence, pathology, and management.

Citing Articles

A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.

Sultana Q, Kar J, Verma A, Sanghvi S, Kaka N, Patel N J Clin Med. 2023; 12(15).

PMID: 37568540 PMC: 10420169. DOI: 10.3390/jcm12155138.

Outcomes of 101 Consecutive Surgical Resections of Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs) at Tata Memorial Hospital: a Referral Bias for Nonfunctional Duodenopancreatic Tumours and the Need for Greater Awareness of GEPNETs as a....

Gaikwad V, Patkar S, Barreto S, Sirohi B, Goel M, Shrikhande S Indian J Surg. 2017; 79(3):226-233.

PMID: 28659676 PMC: 5473788. DOI: 10.1007/s12262-016-1453-6.

Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on....

Basu S, Sirohi B, Shrikhande S Eur J Nucl Med Mol Imaging. 2014; 41(8):1492-6.

PMID: 24863431 DOI: 10.1007/s00259-014-2805-8.

References

Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A . CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol. 2003; 181(4):987-92. DOI: 10.2214/ajr.181.4.1810987. View

Ichikawa T, Peterson M, Federle M, BARON R, Haradome H, Kawamori Y . Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology. 2000; 216(1):163-71. DOI: 10.1148/radiology.216.1.r00jl26163. View

Semelka R, Cumming M, Shoenut J, Magro C, Yaffe C, Kroeker M . Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology. 1993; 186(3):799-802. DOI: 10.1148/radiology.186.3.8381551. View

Murthy R, Kamat P, Nunez R, Madoff D, Gupta S, Salem R . Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol. 2008; 19(1):145-51. DOI: 10.1016/j.jvir.2007.09.006. View

Druce M, Muthuppalaniappan V, OLeary B, Chew S, Drake W, Monson J . Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation. Eur J Endocrinol. 2010; 162(5):971-8. DOI: 10.1530/EJE-10-0056. View

Herwick S, Miller F, Keppke A . MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol. 2006; 187(5):W472-80. DOI: 10.2214/AJR.05.0809. View

Klimstra D, Modlin I, Coppola D, Lloyd R, Suster S . The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010; 39(6):707-12. DOI: 10.1097/MPA.0b013e3181ec124e. View

Sarmiento J, Que F, Grant C, Thompson G, Farnell M, Nagorney D . Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery. 2002; 132(6):976-82; discussion 982-3. DOI: 10.1067/msy.2002.128615. View

Yao J, Phan A, Hoff P, Chen H, Charnsangavej C, Yeung S . Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol. 2008; 26(8):1316-23. DOI: 10.1200/JCO.2007.13.6374. View

10.

Strosberg J, Cheema A, Kvols L . A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract. Cancer Control. 2011; 18(2):127-37. DOI: 10.1177/107327481101800207. View

11.

Plockinger U, Wiedenmann B . Neuroendocrine tumors. Biotherapy. Best Pract Res Clin Endocrinol Metab. 2007; 21(1):145-62. DOI: 10.1016/j.beem.2007.01.002. View

12.

Cao C, Yan T, Bester L, Liauw W, Morris D . Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg. 2010; 97(4):537-43. DOI: 10.1002/bjs.6931. View

13.

Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H . Nonfunctioning neuroendocrine pancreatic tumors: our experience and management. J Hepatobiliary Pancreat Surg. 2009; 16(5):639-47. DOI: 10.1007/s00534-009-0099-1. View

14.

Kloppel G, Rindi G, Perren A, Komminoth P, Klimstra D . The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch. 2010; 456(6):595-7. DOI: 10.1007/s00428-010-0924-6. View

15.

Cohen M, Bower R, Fidler S, Johnsonbaugh R, Sode J . Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma. Lancet. 1973; 1(7793):40-1. DOI: 10.1016/s0140-6736(73)91251-8. View

16.

Raymond E, Dahan L, Raoul J, Bang Y, Borbath I, Lombard-Bohas C . Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011; 364(6):501-13. DOI: 10.1056/NEJMoa1003825. View

17.

Strosberg J, Fine R, Choi J, Nasir A, Coppola D, Chen D . First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer. 2010; 117(2):268-75. PMC: 4665634. DOI: 10.1002/cncr.25425. View

18.

Rhee T, Lewandowski R, Liu D, Mulcahy M, Takahashi G, Hansen P . 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg. 2008; 247(6):1029-35. DOI: 10.1097/SLA.0b013e3181728a45. View

19.

Kwekkeboom D, Teunissen J, Bakker W, Kooij P, de Herder W, Feelders R . Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol. 2005; 23(12):2754-62. DOI: 10.1200/JCO.2005.08.066. View

20.

WHIPPLE A, FRANTZ V . ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW. Ann Surg. 1935; 101(6):1299-335. PMC: 1390871. DOI: 10.1097/00000658-193506000-00001. View